SGCB and diabetic kidney disease: Moreover, we confirmed (in kidneys from both diabetic ZSF1 rats and human subjects with advanced DKD) that lower cGMP effects, a proxy of decreased downstream sGC action, correlated positively with the inability to negatively regulate oxidative stress.